CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in rats

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Psychopharmacology

• Publication date

  2016-05-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1177/0269881116639287PMID 27005309PMCID PMC5531753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Slave to habit? Obesity is associated with decreased behavioural sensitivity to reward devaluation.

  2015cited by this paper
• A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents

  2015cited by this paper
• Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule

  2014cited by this paper
• The endocannabinoid system controls food intake via olfactory processes

  2014cited by this paper
• The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake

  2014cited by this paper
• CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats

  2014cited by this paper
• Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats

  2013cited by this paper
• The selective serotonin reuptake inhibitor paroxetine decreases breakpoint of rats engaging in a progressive ratio licking task for sucrose and quinine solutions.

  2013cited by this paper
• Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade

  2013cited by this paper
• Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice.

  2012cited by this paper
• Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity

  2012cited by this paper
• Rimonabant reduces the essential value of food in the genetically obese Zucker rat: an exponential demand analysis.

  2012cited by this paper
• Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance.

  2012cited by this paper
• Endocannabinoid signal in the gut controls dietary fat intake

  2011cited by this paper
• Effects of satiety on operant responding in rats raised in enrichment

  2011cited by this paper
• Inverse agonism of cannabinoid CB1 receptors potentiates LiCl‐induced nausea in the conditioned gaping model in rats

  2010cited by this paper
• Endocannabinoid control of gastric sensorimotor function in man

  2010cited by this paper
• The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior.

  2010cited by this paper
• Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists.

  2010cited by this paper
• A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents

  2010cited by this paper
• Bimodal control of stimulated food intake by the endocannabinoid system

  2010cited by this paper
• Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113.

  2009cited by this paper
• Endocannabinoids selectively enhance sweet taste

  2009cited by this paper
• Cholecystokinin and gut-brain signalling.

  2009cited by this paper
• Rimonabant induced anorexia in rodents is not mediated by vagal or sympathetic gut afferents.

  2009cited by this paper
• The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

  2008cited by this paper
• The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats.

  2008cited by this paper
• Activating Parabrachial Cannabinoid CB1 Receptors Selectively Stimulates Feeding of Palatable Foods in Rats

  2008cited by this paper
• A comparison of the effects of the CB1 receptor antagonist SR141716A, pre-feeding and changed palatability on the microstructure of ingestive behaviour

  2007cited by this paper
• Effect of delta9-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test.

  2007cited by this paper
• G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences

  2007cited by this paper
• Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.

  2006cited by this paper
• How many sites of action for endocannabinoids to control energy metabolism?

  2006cited by this paper
• Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387.

  2006cited by this paper
• The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food

  2005cited by this paper
• Design and Analysis: A Researcher's Handbook

  2005cited by this paper
• The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats

  2005cited by this paper
• Effect of Delta9-tetrahydrocannabinol on sucrose palatability as measured by the taste reactivity test.

  2005cited by this paper
• Behavioral effects of the novel cannabinoid full agonist AM 411.

  2005cited by this paper
• Reduced sensitivity to reward in CB1 knockout mice

  2004cited by this paper
• Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A.

  2004cited by this paper
• Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats.

  2004cited by this paper
• The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin

  2004cited by this paper
• The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

  2003cited by this paper
• Effects of systematic variation in presatiation and fasting on the behavioural satiety sequence in male rats.

  2003cited by this paper
• Palatability, food intake and the behavioural satiety sequence in male rats.

  2003cited by this paper
• The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats

  2003cited by this paper
• Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after Δ9-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716

  2003cited by this paper
• Effects of antipsychotic drugs on operant responding after acute and repeated administration

  2002cited by this paper
• A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing

  1998cited by this paper
• SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.

  1998cited by this paper
• The effects of nucleus accumbens dopamine depletions on continuously reinforced operant responding: contrasts with the effects of extinction.

  1995cited by this paper
• Distinguishing between haloperidol's and decamethonium's disruptive effects on operant behavior in rats: use of measurements that complement response rate.

  1991cited by this paper
• Operant regulation of feeding: a static analysis.

  1983cited by this paper
• Comparison of Stopping Rules in Forward Stepwise Discriminant Analysis

  1979cited by this paper
• A model for the control of ingestion.

  1977cited by this paper
• Interresponse time changes as a function of water deprivation and amphetamine.

  1975cited by this paper
• Satiation effects under fixed-ratio schedules of reinforcement.

  1954cited by this paper

• Effects of the Neutral CB1 Receptor Antagonist AM6527 on Spontaneous, Consummatory, and Motivated Behavior in Mice

  2025cites this paper
• The Endocannabinoid System and Eating Behaviours: a Review of the Current State of the Evidence

  2022cites this paper
• "Photo-Rimonabant": Synthesis and Biological Evaluation of Novel Photoswitchable Molecules Derived from Rimonabant Lead to a Highly Selective and Nanomolar "Cis-On" CB1R Antagonist.

  2021cites this paper
• CHARACTERIZING AN IN VITRO MODEL OF SEVERE FOCAL TRAUMATIC BRAIN INJURY IN HIPPOCAMPAL SLICE CULTURES: THE EFFECTS OF ETHANOL AND CALPAIN INHIBITION BY MDL-28170

  2019cites this paper
• Using mildly electrified grids to impose costs on resource access: A potential tool for assessing motivation in laboratory mice

  2018cites this paper
• Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling

  2018cites this paper
• Cannabimimetic phytochemicals in the diet – an evolutionary link to food selection and metabolic stress adaptation?

  2017cites this paper
• The Role of Peripheral glycine receptors in cannabinoid-induced feeding

  2017cites this paper
• Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor

  2017influential citation
• Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin.

  2016cites this paper
• Validating Methods that Promote Reduction and Refinement in Laboratory Animal Science

  2016cites this paper